SCHEMBL16656334

SCHEMBL16656334

N#CCCOP(N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL55353 0.83 ALDH1A1 (0.37)
SCHEMBL19418536 0.79
SCHEMBL3863161 0.79
SCHEMBL4826277 0.79
SCHEMBL9436380 0.79
SCHEMBL23384087 0.79
SCHEMBL55354 0.79
Hydrochloric Acid SCHEMBL17225016 0.77
Hydrogen Sulfide SCHEMBL27463519 0.77 LOX (0.32)
SCHEMBL1500279 0.77 ALDH1A1 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023016999-A2 Compounds Cargene Therapeutics Pte. Ltd. (SG) 2023-02-16 WO disclosed
US-20150191727-A1 BICYCLIC CYCLOHEXOSE NUCLEIC ACID ANALOGS ISIS PHARMACEUTICALS, INC. (US) 2015-07-09 US disclosed
US-9045750-B2 Humanized lewis-Y specific antibody-based delivery of dicer substrate siRNA (D-siRNA) against STAT3 MA YUELONG (US) 2015-06-02 US disclosed
US-9012421-B2 Bicyclic cyclohexose nucleic acid analogs ISIS PHARMACEUTICALS, INC. (US) 2015-04-21 US disclosed